Aspect Partners’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$145K Hold
570
0.05% 94
2026
Q1
$139K Hold
570
0.06% 91
2025
Q4
$118K Hold
570
0.05% 97
2025
Q3
$106K Sell
570
-302
-35% -$51.7K 0.05% 107
2025
Q2
$133K Buy
872
+300
+52% +$46.1K 0.07% 96
2025
Q1
$94.9K Sell
572
-2
-0.3% -$313 0.05% 98
2024
Q4
$83K Sell
574
-1
-0.2% -$155 0.05% 107
2024
Q3
$93.2K Buy
575
+1
+0.2% +$159 0.05% 95
2024
Q2
$83.9K Sell
574
-5
-0.9% -$744 0.05% 98
2024
Q1
$91.6K Buy
579
+1
+0.2% +$159 0.07% 94
2023
Q4
$90.6K Buy
+578
New +$88.6K 0.06% 89

Other funds holding JNJ

Aspect Partners's JNJ Position: Q2 2026 in Review

Aspect Partners held its Johnson & Johnson (JNJ) position steady in Q2 2026 at 570 shares worth $145K. The position accounts for 0.05% of the portfolio, ranked #94.

Aspect Partners first reported a position in JNJ in Q4 2023 and has held it in 11 quarters since. 1,657 funds tracked by Wall St. Rank hold JNJ as of Q2 2026.

  • Aspect Partners held 570 shares of Johnson & Johnson worth $145K as of Q2 2026.
  • Aspect Partners left its Johnson & Johnson share count unchanged in Q2 2026.
  • Johnson & Johnson made up 0.05% of Aspect Partners's portfolio in Q2 2026, its #94 holding.
  • Aspect Partners first reported a position in Johnson & Johnson in Q4 2023 and has held it in 11 quarters since.
  • 1,657 funds tracked by Wall St. Rank held Johnson & Johnson as of Q2 2026.

Based on Aspect Partners's 13F filing for Q2 2026, filed 16 Jul 2026.